The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Myrtelle Inc. announced that the FDA granted Regenerative Medicine Advanced Therapy (RMAT) Designation to the Company's lead gene therapy product ...
read more
Ipsen and Sutro Biopharma announced an exclusive global licensing agreement for STRO-003. STRO-003, an antibody-drug conjugate (ADC) in the final ...
read more
Agilent Technologies Inc. and the University of California San Diego (UC San Diego), one of the top-ranked public research universities in the world, ...
read more
Apotex Inc. and Searchlight Pharma Inc. announced that they have reached an agreement whereby Apotex will acquire Searchlight.
read more
AvKARE, LLC. is voluntarily recalling lot # AW0221A of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the potential ...
read more
The Board of Directors of Lonza announced that Wolfgang Wienand has been appointed Chief Executive Officer (CEO), and will join the company during the...
read more
Bora Pharmaceuticals Co., Ltd. announced that it has completed the acquisition of Upsher-Smith Laboratories, Inc. (“Upsher-Smith”), a generics ...
read more
Ginkgo Bioworks announced the acquisition of Modulus Therapeutics' cell therapy platform assets, including their chimeric antigen receptor (CAR) and ...
read more
Bayer announced Sue Ann Pentecost as the new Vice President, Head of Pharmaceuticals Communications in the United States. She will report directly to ...
read more
Bristol Myers Squibb announced an update following the initial analysis of results from the first of two induction studies in the Phase 3 YELLOWSTONE ...
read more
Amneal Pharmaceuticals is recalling 4 lots of Vancomycin Hydrochloride for Oral Solution USP, 250 mg/ 5mL packaged in 80 mL, 150 mL, or 300 mL pack ...
read more
Voydeya (danicopan) has been approved in the US as add-on therapy to ravulizumab or eculizumab for the treatment of extravascular haemolysis (EVH) in ...
read more
Merck announced that the European Commission (EC) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with platinum-containing ...
read more
CSL Vifor announced that its partner Akebia Therapeutics, Inc. has received FDA approval for Vafseo (vadadustat) tablets for the treatment of anemia ...
read more
Astellas Pharma Inc. announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted the...
read more